強気
$29.90
シナリオ価格
$31.670
+1.507 (+4.76%)終値時点
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting.
Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.
Raymond James
$39
2026-09-28
Raymond James
2026-09-28
目標株価
$39
Leerink
$33
2026-09-23
Leerink
2026-09-23
目標株価
$33
Guggenheim
$39
2026-07-30
Guggenheim
2026-07-30
目標株価
$39
Barclays
$32
2026-07-30
Barclays
2026-07-30
目標株価
$32
BofA
$13
2026-07-29
BofA
2026-07-29
目標株価
$13
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Acadia Healthcare to Release Q3 2026 Results and Host Conference Call

Halper Sadeh LLC Investigates Acadia Healthcare Management Responsibilities

Halper Sadeh LLC Investigates Acadia Healthcare Executives' Fiduciary Duties

Investigation into Acadia Healthcare Shareholder Rights

Investment Watchlist: Small-Cap Stocks and Risks
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates in the Healthcare sector (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC industry).
Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.
17 analysts cover ACHC: 10 rate it Buy, 7 Hold and 0 Sell. The average price target is 18.10.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。